Silexion Therapeutics completes 1-for-10 reverse share split; warrants adjusted

Silexion Therapeutics Corp

1-for-10 reverse share split effective after close May 28; shares trade on split-adjusted basis May 29 under ticker SLXN.
Authorized shares reduced to 5.9M; par value increased to $0.135 per share.
Each warrant now exercisable for 1/10 share at $15,525.00 per whole share (was $1,552.50).
Shareholders approved reverse split at reconvened EGM on May 5, 2026.
Split intended to maintain compliance with Nasdaq minimum bid price requirement.

item 3.03 item 5.03 item 8.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001178913-26-002988
form_type: 8-K
ticker: SLXN
cik: 0002022416
company_name: Silexion Therapeutics Corp
filed_at: 2026-05-29T11:00:25+00:00
discovered_at: 2026-05-29T11:05:00.275125+00:00
generated_at: 2026-05-29T11:05:40.234955+00:00
sec_items: ["3.03", "5.03", "8.01", "9.01"]
event_type: regulatory
sentiment: negative
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001178913-26-002988
json_url: https://secwatch.observer/filing/0001178913-26-002988.json
markdown_url: https://secwatch.observer/filing/0001178913-26-002988.md
text_url: https://secwatch.observer/filing/0001178913-26-002988.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/2022416/000117891326002988/0001178913-26-002988-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/2022416/000117891326002988/zk2635442.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Comparable filings

AWK

Kentucky-American Water files $17.7M rate case; shareholders approve charter amendment, equity plan

American Water Works Company, Inc. May 15, 2026, 4:34 PM ET regulatory Items 5.02, 5.07, 5.03, 8.01, 9.01

same SEC item: 5.03, 8.01, 9.01 same event type: regulatory similar materiality

Filing page SEC filing

Richtech Robotics receives Nasdaq delisting notice for late Q1 10-Q filing

RICHTECH ROBOTICS INC. May 28, 2026, 4:49 PM ET regulatory Items 3.01, 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: regulatory similar materiality

Filing page SEC filing

GROO

Groovy dismisses auditor after SEC suspension, reduces authorized common 99.5%, two officers depart

GROOVY COMPANY, INC. May 28, 2026, 3:28 PM ET regulatory Items 4.01, 4.02, 5.03, 5.02, 9.01

same SEC item: 5.03, 9.01 same event type: regulatory similar materiality

Filing page SEC filing

JAGX

Jaguar Health regains Nasdaq Bid Price compliance; monitoring until May 2027

Jaguar Health, Inc. May 27, 2026, 9:10 AM ET regulatory Items 7.01, 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: regulatory similar materiality

Filing page SEC filing

MBOT

Microbot Medical receives Israeli regulatory approval for LIBERTY System, first outside U.S.

Microbot Medical Inc. May 26, 2026, 8:30 AM ET regulatory Items 7.01, 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: regulatory similar materiality

Filing page SEC filing

LRHC

La Rosa Holdings receives Nasdaq deficiency notice for late 10-K and 10-Q filings

La Rosa Holdings Corp. May 22, 2026, 5:20 PM ET regulatory Items 3.01, 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: regulatory similar materiality

Filing page SEC filing

AVXL

Anavex receives Nasdaq delinquency notice for late 10-Q filing; deadline July 20, 2026

ANAVEX LIFE SCIENCES CORP. May 22, 2026, 8:15 AM ET regulatory Items 3.01, 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: regulatory similar materiality

Filing page SEC filing

ADGM

Adagio submits PMA to FDA for vCLAS VT ablation system; trial shows 97.4% acute success

Adagio Medical Holdings, Inc. May 21, 2026, 4:31 PM ET regulatory Items 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: regulatory similar materiality

Filing page SEC filing

Source: SEC EDGAR

accession 0001178913-26-002988

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.